Dennis Polk - 01 Nov 2021 Form 4 Insider Report for Concentrix Corp (CNXC)

Role
Director
Signature
/s/ Andrew A. Farwig, Attorney-in-Fact
Issuer symbol
CNXC
Transactions as of
01 Nov 2021
Net transactions value
-$698,416
Form type
4
Filing time
03 Nov 2021, 18:11:16 UTC
Previous filing
21 Oct 2021
Next filing
03 Dec 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CNXC Common Stock Options Exercise $189,700 +5,000 +18% $37.94 32,532 01 Nov 2021 Direct
transaction CNXC Common Stock Sale $34,768 -200 -0.61% $173.84 32,332 01 Nov 2021 Direct F1, F2
transaction CNXC Common Stock Sale $70,036 -400 -1.2% $175.09 31,932 01 Nov 2021 Direct F1, F3
transaction CNXC Common Stock Sale $122,988 -700 -2.2% $175.70 31,232 01 Nov 2021 Direct F1, F4
transaction CNXC Common Stock Sale $395,040 -2,222 -7.1% $177.79 29,010 01 Nov 2021 Direct F1, F5
transaction CNXC Common Stock Sale $32,620 -183 -0.63% $178.25 28,827 01 Nov 2021 Direct F1, F6
transaction CNXC Common Stock Sale $232,664 -1,295 -4.5% $179.66 27,532 01 Nov 2021 Direct F1, F7

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CNXC Employee Stock Option (Right to Buy) Options Exercise $0 -5,000 -8.1% $0.000000 57,101 01 Nov 2021 Common Stock 5,000 $37.94 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 19, 2021.
F2 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $173.41 to $174.29, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $174.56 to $175.52, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $175.56 to $175.98, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $177.22 to $178.21, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F6 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $178.24 to $178.26, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F7 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $179.37 to $180.155, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F8 The stock option vested as to 20% of the shares on October 11, 2019, the first anniversary of the date of grant, and vests as to 1/60th of the shares monthly thereafter.